Associate Professor Valderilio Feijó Azevedo, MD, PhD, MSc

Member of International Advisory Board, GaBI Journal

Associate Professor of Rheumatology
Former Head of the Rheumatology Unit
Hospital de Clínicas, Federal University of Paraná-UFPR, Brazil

Since 2009, Professor Feijó Azevedo has been the owner and principal investigator of EDUMED Health Research and Education, as well as EDUMED Biotech.

Professor Feijó Azevedo’s major research interests include clinical trials, regulatory advances in biologics therapies, spondyloarthritis, new treatment strategies for autoimmune diseases, biologicals and biosimilars and translational research in SpA. He has authored several publications in the field.

Professor Feijó Azevedo is member of the Brazilian Commitee of Psoriatic Arthritis, coordinator of the Brazilian Commitee of Biotechnology at the Brazilian Society of Rheumatology. He is also a member of GRAPPA – Group for Research and Assessment of Psoriasis and Psoriatic Arthritis, EUSTAR – EULAR scleroderma trials and research group, and a former member of ASAS-Assessment of Spondyloarthritis International Society.

Professor Feijó Azevedo is an Executive Board Member of Americas Health Foundation, Washington DC, USA. He has worked on projects on pharmacovigillance of biologicals and biosimilars and spondyloarthritis and has been the coordinator of the Latin American Forum on Biosimilars–FLAB since 2010. He is also the Advisory Board Member of the Alliance for Safe Biologics Medicines, Washington DC, USA.